This page shows the latest medicines use news and features for those working in and with pharma, biotech and healthcare.
However, AZ did report that the pandemic had a significant impact on certain medicines, including sales of asthma/COPD treatment Pulmicort (budesonide) in China and some decreased use of infused/injectable ... medicines such as Imfinzi and monoclonal
Xeljanz is approved in the US for use in adults with rheumatoid arthritis (RA) who have not responded well to methotrexate treatment. ... Providing information on the safe and effective use of our medicines is imperative,” said Tamas Koncz, chief
Last week, the FDA approved Pfizer/BioNTech’s mRNA-based COVID-19 vaccine BNT162b2, granting it a conditional approval for emergency use in the US. ... Moderna's mRNA-1273 vaccine is also under review by the European Medicines Agency (EMA) for
New infrastructure will support real-world studies. The European Medicines Agency (EMA) has set up new infrastructure to support the use of real-world monitoring of potential treatments and vaccines for ... Another contract, agreed in June, saw the EMA
The UK’s medicines watchdog NICE and the Scottish Medicines Consortium recently backed the use of Mulpleo in this patient population after determining that the drug was cost-effective. ... Earlier this month, NICE also published final draft guidance
Mayzent (siponimoid), developed by Swiss pharma Novartis, has received a positive opinion from the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) for the treatment of ... Safety reviews of Lemtrada and
More from news
Approximately 0 fully matching, plus 266 partially matching documents found.
Access to healthcare, including affordable medicines, remains a top concern across the US. ... This can help expand options for chronically ill patients and allow greater use of biologic medicines by providing more affordable access to individuals who,
The FDA has just granted Roche emergency use authorisation (EUA) for its new test to detect the virus that causes the coronavirus. ... Secondly, the revised Patents Act encourages the development of safe medicinal products for paediatric use.
drugs on a trial basis – de-linking the valuation and reward payments from the medicines’ usage. ... by 2024. The plan also supports increased use of a ‘precision medicines’ approach increasing the percentage of prescriptions informed by
of medicines to use. ... We make sure the science is understood and we use that feedback to make sure our medicines are available and used in the right way.
We appreciate that our partnership with the FDA has allowed us to take a significant step forward in the use of real-world data to bring medicines to patients who are ... Real-world data is playing an increasingly important role in expanding the use of
More from intelligence
Approximately 1 fully matching, plus 39 partially matching documents found.
Prior to joining Accord, Grosso held a number of senior public and commercial roles, including the role of principal medicines management pharmacist at UCL Hospitals. ... Grosso is also a registered pharmacist, and has a long-standing interest in the
the access to and use of new and innovative medicines for Scottish patients. . ... and innovative medicines.”.
team. “His experience in both government and the pharmaceutical industry will prove invaluable when addressing the issues of access and use of new medicines in the NHS and in leading discussions
As president of the EAHP, Peppard will look to advance the organisation's mission to develop hospital pharmacy in order to promote the best and safest use of medicines and medical
Rowland will work on a range of projects to improve patient access to innovative medicines, in line with the ABPI's strategic objectives around health technology assessment and market access. ... greater use of newer medicines,” added Catchpole.
More from appointments
Approximately 0 fully matching, plus 10 partially matching documents found.
“Take up of new medicines in the UK continues to be slow by international standards”. ... Yet with the sector seen as crucial to economic regeneration post-Brexit and post-pandemic, the slower use of innovative medicines in the UK is a drag anchor on
Targeted therapies for ovarian cancer. In 2011, the European Medicines Agency (EMA) approved the use of targeted therapies, including an anti-angiogenic treatment alongside chemotherapy to increase the effectiveness of treatment ... Zejula. Available at:
by 2020/21 if the NHS embraces the use of best value biological medicines in a proactive, systematic and safe way’. ... The best biologics agenda and pharma. In line with the Commissioning Framework for Biological Medicines, NHS England, NHS
The conference brings together HCPs, patients, payers, government, pharma and industry under one roof to focus on patients’ engagement and experience of their treatment to improve the real-world use of ... medicines.Speaking at the conference .
There is a huge amount of off-label use of licensed medicines by medically qualified prescribers. ... There are also many agents that have crossed the line from illegal to legal use, such as cannabinoids for MS, as well as previously approved medicines
More from PMHub
Approximately 0 fully matching, plus 11 partially matching documents found.
For those who can imagine better, Page & Page and Partners (P&P) is home to meaningful encounters of a marketing, communication...